|
1
|
Al-Jaghbeer M, Dealmeida D, Bilderback A,
Ambrosino R and Kellum JA: Clinical decision support for
in-hospital AKI. J Am SocNephrol. 29:654–660. 2018.
|
|
2
|
Zarbock A, Koyner JL, Hoste EAJ and Kellum
JA: Update on perioperative acute kidney injury. Anesth Analg.
127:1236–1245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chertow GM, Burdick E, Honour M, Bonventre
JV and Bates DW: Acute kidney injury, mortality, length of stay,
and costs in hospitalized patients. J Am Soc Nephrol. 16:3365–3370.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gameiro J, Fonseca JA, Neves M, Jorge S
and Lopes JA: Acute kidney injury in major abdominal surgery:
Incidence, risk factors, pathogenesis and outcomes. Ann Intensive
Care. 8:222018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin J, Wang Y, Shen Q, Gong J, Zhao L and
He Q: Acute kidney injury in cancer patients: A nationwide survey
in China. Sci Rep. 9:35402019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Izzedine H and Perazella MA: Anticancer
drug-induced acute kidney injury. Kidney Int Rep. 2:504–514. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dilruba S and Kalayda GV: Platinum-based
drugs: Past, present and future. Cancer Chemother Pharmacol.
77:1103–1124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pabla N and Dong Z: Cisplatin
nephrotoxicity: Mechanisms and renoprotective strategies. Kidney
Int. 73:994–1007. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manohar S and Leung N: Cisplatin
nephrotoxicity: A review of the literature. J Nephrol. 31:15–25.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miao ZF, Liu XY, Wang ZN, Zhao TT, Xu YY,
Song YX, Huang JY, Xu H and Xu HM: Effect of neoadjuvant
chemotherapy in patients with gastric cancer: A PRISMA-compliant
systematic review and meta-analysis. BMC Cancer. 18:1182018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee EH, Kim HR, Baek SH, Kim KM, Chin JH,
Choi DK, Kim WJ and Choi IC: Risk factors of postoperative acute
kidney injury in patients undergoing esophageal cancer surgery. J
Cardiothorac Vasc Anesth. 28:936–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salahudeen AK, Doshi SM, Pawar T, Nowshad
G, Lahoti A and Shah P: Incidence rate, clinical correlates, and
outcomes of AKI in patients admitted to a comprehensive cancer
center. Clin J Am Soc Nephrol. 8:347–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oh GS, Kim HJ, Shen A, Lee SB, Khadka D,
Pandit A and So HS: Cisplatin-induced kidney dysfunction and
perspectives on improving treatment strategies. Electrolyte Blood
Press. 12:55–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan M, Shu S, Guo C, Tang C and Dong Z:
Endoplasmic reticulum stress in ischemic and nephrotoxic acute
kidney injury. Ann Med. 50:381–390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Volarevic V, Djokovic B, Jankovic MG,
Harrell CR, Fellabaum C, Djonov V and Arsenijevic N: Molecular
mechanisms of cisplatin-induced nephrotoxicity: A balance on the
knife edge between renoprotection and tumor toxicity. J Biomed Sci.
26:252019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bravo R, Parra V, Gatica D, Rodriguez AE,
Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E,
et al: Endoplasmic reticulum and the unfolded protein response:
Dynamics and metabolic integration. Int Rev Cell Mol Biol.
301:215–290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
García de la Cadena S and Massieu L:
Caspases and their role in inflammation and ischemic neuronal
death. Focus on caspase-12. Apoptosis. 21:763–777. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen B, Liu G, Zou P, Li X, Hao Q, Jiang
B, Yang X and Hu Z: Epigallocatechin-3-gallate protects against
cisplatin-induced nephrotoxicity by inhibiting endoplasmic
reticulum stress-induced apoptosis. Exp Biol Med (Maywood).
240:1513–1519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Z, Liu G, Hu Z and Li X, Yang X, Jiang
B and Li X: Grape seed proanthocyanidin extract protects from
cisplatin-induced nephrotoxicity by inhibiting endoplasmic
reticulum stress-induced apoptosis. Mol Med Report. 9:801–807.
2014. View Article : Google Scholar
|
|
20
|
Gong X, Shao L, Fu YM and Zou Y: Effects
of olmesartan on endothelial progenitor cell mobilization and
function in carotid atherosclerosis. Med Sci Monit. 21:1189–1193.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuwana H, Terada Y, Kobayashi T, Okado T,
Penninger JM, Irie-Sasaki J, Sasaki T and Sasaki S: The
phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular
injury in cisplatin nephrotoxicity. Kidney Int. 73:430–445. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Feng X, Hu X, Sha J, Li B, Zhang H
and Fan H: Dexmedetomidine ameliorates acute stress-induced kidney
injury by attenuating oxidative stress and apoptosis through
inhibition of the ROS/JNK signaling pathway. Oxid Med Cell Longev.
2018:40353102018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y, Luan L, Wang C, Song M, Zhao Y,
Yao Y, Yang H, Ma B and Fan H: Dexmedetomidine protects against
lipopolysaccharide-induced early acute kidney injury by inhibiting
the iNOS/NO signaling pathway in rats. Nitric Oxide. 85:1–9. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Si Y, Bao H, Han L, Chen L, Zeng L, Jing
L, Xing Y and Geng Y: Dexmedetomidine attenuation of renal
ischaemia-reperfusion injury requires sirtuin 3 activation. Br J
Anaesth. 121:1260–1271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiu R, Yao W, Ji H, Yuan D, Gao X, Sha W,
Wang F, Huang P and Hei Z: Dexmedetomidine restores septic renal
function via promoting inflammation resolution in a rat sepsis
model. Life Sci. 204:1–8. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang H, Liu HZ, Wang HB, Zhong JY, Yang
CX and Zhang B: Dexmedetomidine protects against cisplatin-induced
acute kidney injury in mice through regulating apoptosis and
inflammation. Inflamm Res. 66:399–411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu C, Fu Q, Mu R, Wang F, Zhou C, Zhang
L, Yu B, Zhang Y, Fang T and Tian F: Dexmedetomidine alleviates
cerebral ischemia-reperfusion injury by inhibiting endoplasmic
reticulum stress dependent apoptosis through the
PERK-CHOP-Caspase-11 pathway. Brain Res. 1701:246–254. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng XY, Gu XY, Gao Q, Zong QF, Li XH and
Zhang Y: Effects of dexmedetomidine postconditioning on myocardial
ischemia and the role of the PI3K/Akt-dependent signaling pathway
in reperfusion injury. Mol Med Rep. 14:797–803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
National Research Council: Guide for the
care and use of laboratory animals: Eighth edition. Washington, DC:
The National Academies Press; 2011
|
|
30
|
Zhang W, Zhang JQ, Meng FM and Xue FS:
Dexmedetomidine protects against lung ischemia-reperfusion injury
by the PI3K/Akt/HIF-1α signaling pathway. J Anesth. 30:826–833.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Alhoshani AR, Hafez MM, Husain S,
Al-Sheikh AM, Alotaibi MR, Al Rejaie SS, Alshammari MA, Almutairi
MM and Al-Shabanah OA: Protective effect of rutin supplementation
against cisplatin-induced Nephrotoxicity in rats. BMC Nephrol.
18:1942017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perše M and Večerić-Haler Ž:
Cisplatin-induced rodent model of kidney injury: Characteristics
and challenges. Biomed Res Int. 2018:14628022018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schröder M and Kaufman RJ: The mammalian
unfolded protein response. Annu Rev Biochem. 74:739–789. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Potočnjak I and Domitrović R: Carvacrol
attenuates acute kidney injury induced by cisplatin through
suppression of ERK and PI3K/Akt activation. Food Chem Toxicol.
98:251–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gu J, Sun P, Zhao H, Watts HR, Sanders RD,
Terrando N, Xia P, Maze M and Ma D: Dexmedetomidine provides
renoprotection against ischemia-reperfusion injury in mice. Crit
Care. 15:R1532011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mahgoub E, Kumaraswamy SM, Kader KH,
Venkataraman B, Ojha S, Adeghate E and Rajesh M: Genipin attenuates
cisplatin-induced nephrotoxicity by counteracting oxidative stress,
inflammation, and apoptosis. Biomed Pharmacother. 93:1083–1097.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang L, Gu Y, Li H, Cao H, Liu B, Zhang H
and Shao F: Daphnetin protects against cisplatin-induced
nephrotoxicity by inhibiting inflammatory and oxidative response.
Int Immunopharmacol. 65:402–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang W, Hou J, Yan X, Leng J, Li R, Zhang
J, Xing J, Chen C, Wang Z and Li W: Platycodon grandiflorum
saponins ameliorate cisplatin-induced acute nephrotoxicity through
the NF-κB-mediated inflammation and PI3K/Akt/apoptosis signaling
pathways. Nutrients. 10(pii): E13282018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin JH, Li H, Yasumura D, Cohen HR, Zhang
C, Panning B, Shokat KM, Lavail MM and Walter P: IRE1 signaling
affects cell fate during the unfolded protein response. Science.
318:944–949. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Soni KK, Kim HK, Choi BR, Karna KK, You
JH, Cha JS, Shin YS, Lee SW, Kim CY and Park JK: Dose-dependent
effects of cisplatin on the severity of testicular injury in
Sprague Dawley rats: Reactive oxygen species and endoplasmic
reticulum stress. Drug Des Devel Ther. 10:3959–3968. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Singh MP, Chauhan AK and Kang SC: Morin
hydrate ameliorates cisplatin-induced ER stress, inflammation and
autophagy in HEK-293 cells and mice kidney via PARP-1 regulation.
Int Immunopharmacol. 56:156–167. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu XR, Li T, Cao L, Yu YY, Chen LL, Fan
XH, Yang BB and Tan XQ: Dexmedetomidine attenuates H2O2-induced
neonatal rat cardiomyocytes apoptosis through mitochondria- and
ER-medicated oxidative stress pathways. Mol Med Report.
17:7258–7264. 2018.
|
|
43
|
Fruman DA, Meyers RE and Cantley LC:
Phosphoinositide kinases. Annu Rev Biochem. 67:481–507. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou MF, Feng ZP, Ou YC, Peng JJ, Li K,
Gong HD, Qiu BH, Liu YW, Wang YJ and Qi ST: Endoplasmic reticulum
stress induces apoptosis of arginine vasopressin neurons in central
diabetes insipidus via PI3K/Akt pathway. CNS Neurosci Ther.
25:562–574. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kong D, Zhuo L, Gao C, Shi S, Wang N,
Huang Z, Li W and Hao L: Erythropoietin protects against
cisplatin-induced nephrotoxicity by attenuating endoplasmic
reticulum stress-induced apoptosis. J Nephrol. 26:219–227. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shen M, Wang S, Wen X, Han XR, Wang YJ,
Zhou XM, Zhang MH, Wu DM, Lu J and Zheng YL: Dexmedetomidine exerts
neuroprotective effect via the activation of the PI3K/Akt/mTOR
signaling pathway in rats with traumatic brain injury. Biomed
Pharmacother. 95:885–893. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wu CT, Sheu ML, Tsai KS, Weng TI, Chiang
CK and Liu SH: The role of endoplasmic reticulum stress-related
unfolded protein response in the radiocontrast medium-induced renal
tubular cell injury. Toxicol Sci. 114:295–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
